Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hangzhou Minsheng Pharmaceutical Research Institute is the dedicated research and development subsidiary of the Hangzhou Minsheng Pharmaceutical Group, one of China's oldest pharmaceutical enterprises founded in 1926. The institute focuses on the discovery and development of innovative small molecule drugs, high-end generic formulations, and specialized nutritional products. Its core research areas include oncology, cardiovascular diseases, and digestive health, supported by advanced platforms for chemical synthesis and pharmaceutical analysis. The institute plays a critical role in maintaining the group's competitive edge by advancing a diverse pipeline from early-stage discovery through clinical development. It is headquartered in Hangzhou's high-tech industrial zone and collaborates with various academic and industrial partners to drive medical innovation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hangzhou Minsheng Pharmaceutical Research Institute.